Researchers at Penn Medicine have developed an AI pipeline that identified GPNMB, a protein target for CAR T-cell therapy, across multiple cancer types. The system analyzed over 10,000 potential targets and conducted 1,000 simulations to validate its findings, demonstrating potential for new cancer immunotherapies. AI
IMPACT This AI-driven discovery could accelerate the development of new immunotherapies for various cancers.
RANK_REASON AI pipeline used for novel protein discovery in cancer research. [lever_c_demoted from research: ic=1 ai=1.0]
Read on Mastodon — fosstodon.org →
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →
